FUSO CHEMICAL CO.,LTD. FY03/2024 Financial Results
For the year ended March 31, 2024
May 17, 2023
Prime Market（4368）
Tokyo Stock Exchange, Inc.
Table of Contents
- Financial Summary Results for FY03/2024
(period April 1, 2023 - March 31, 2024)
- Segments Results
Life Science
Electronic Materials & Functional Chemicals
- FY03/2025 Outlook
(period April 1, 2024 - March 31, 2025)
I. FY03/2024 Financial Summary
(period April 1, 2023 - March 31, 2024)
Copyright©2024 Fuso Chemical Co.,Ltd. All Rights Reserved. | 3 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2024 （FY03/2024)
（unit：100 millions of yen） | FY03/2024 | vs FY03/2023 | Plan disclosed in May.2023 | Plan disclosed in Sep.2023 | ||||||||
FY03/2023 | YoY | YoY ratio | Plan | Change | vs budget | Plan | Change | vs budget | ||||
Net sales | 589.7 | 684.5 | △94.8 | △13.9% | 693.0 | △103.2 | △14.9% | 605.0 | △15.2 | △2.5% | ||
Operating profit | 110.8 | 189.3 | △78.4 | △41.4% | 138.0 | △27.1 | △19.7% | 109.5 | ＋1.3 | ＋1.2% | ||
Ordinary profit | 118.8 | 197.4 | △78.5 | △39.8% | 138.0 | △19.1 | △13.9% | 115.5 | ＋3.3 | ＋2.9% | ||
Profit | ||||||||||||
Profit | ||||||||||||
attributable to | 83.4 | 141.2 | △57.8 | △41.0% | 94.5 | △11.0 | △11.7% | 79.0 | ＋4.4 | ＋5.6% | ||
owners of parent | ||||||||||||
attributable to | ||||||||||||
owners of parent | ||||||||||||
EBITDA | 182.4 | 232.6 | △50.2 | △21.6% | 217.0 | △34.5 | △15.9% | 182.5 | ＋0.0 | △0.0% | ||
Earnings per | ¥236.7 | ¥400.9 | △¥164.2 | △41.0% | ¥268.1 | △¥31.4 | △11.7% | ¥224.1 | ¥12.5 | ＋5.6% | ||
share | ||||||||||||
Achieved plans of operating profit and profit attributable to owners of parent
Copyright©2024 Fuso Chemical Co.,Ltd. All Rights Reserved. | 4 |
Sales & Profit by segment versus previous year FY03/2023 | |||||||||
FY03/2024 | YoY | ||||||||
(unit:100 millions of yen) | FY03/2023 | change | Ratio | ||||||
▬Life Science | Net sales | 341.4 | 378.0 | △36.6 | △9.7% | ||||
Operating | 56.3 | 74.0 | △17.6 | △23.9% | |||||
profit | |||||||||
▬Electronic Materials | Net sales | 248.2 | 306.5 | △58.2 | △19.0% | ||||
& Functional Chemicals | Operating | 75.3 | 133.9 | △58.6 | △43.8% | ||||
profit | |||||||||
(Adjustment) | △20.8 | △18.6 | △2.1 | ー | |||||
Operating pfofit (consolidated) | 110.8 | 189.3 | △78.4 | △41.4% |
Copyright©2024 Fuso Chemical Co.,Ltd. All Rights Reserved. | 5 |
Net Sales by Segment
(unit:100 ｍillions of yen) | 3/'19 | 3/'20 | 3/'21 | 3/'22 | 3/'23 | 3/'24 |
Net Sales | 420 | 413 | 422 | 557 | 684 | 589 |
Life Science | 252 | 241 | 234 | 314 | 378 | 341 |
Electronic Materials & | 168 | 171 | 187 | 243 | 306 | 248 |
Functional Chemicals |
（unit：100 millions of yen） | FUSO VISION 2025 | 684 | ||||
700 | ||||||
589 | ||||||
600 | 557 | |||||
500 | 420 | 413 | 422 | 378 | 341 | |
400 | 314 | |||||
300 | 252 | 241 | 234 | |||
200 | 306 | 248 | ||||
100 | 168 | 171 | 187 | 243 | ||
0 | 3/'19 | 3/'20 | 3/'21 | 3/'22 | 3/'23 | 3/'24 |
Copyright©2024 Fuso Chemical Co.,Ltd. All Rights Reserved. | 6 |
Operating Profit by Segment
(unit:100 ｍillions of yen) | 3/'19 | 3/'20 | 3/'21 | 3/'22 | 3/'23 | 3/'24 | |
Operating Profit | 92 | 88 | 96 | 150 | 189 | 110 | |
Life Science | 35 | 43 | 33 | 49 | 74 | 56 | |
Electronic Materials & | 69 | 57 | 76 | 116 | 133 | 75 | |
Functional Chemicals | |||||||
(Adjustment) | △ 11 | △ 12 | △ 13 | △ 15 | △ 18 | △ 20 |
230 （unit: 100 millions of yen) | 189 |
180 | 150 | 74 | ||||
110 | ||||||
130 | 92 | 96 | 49 | |||
88 | ||||||
80 | 35 | 43 | 33 | 56 | ||
133 | ||||||
116 | ||||||
69 | 76 | 75 | ||||
30 | 57 | |||||
△ 20 | △ 11 | △ 12 | △ 13 | △ 15 | △ 18 | △ 20 |
3/'19 | 3/'20 | 3/'21 | 3/'22 | 3/'23 | 3/'24 | |
60% | Profit ratio | ||||
50% | 47.7% | 43.7% | |||
41.3% | 40.7% | ||||
40% | 33.4% | 30.3% | |||
30% | |||||
20% | 17.9% | 15.7% | 19.6% | 16.5% | |
13.9% | 14.1% | ||||
10% | Electronic Materials & Functional | ||||
Chemicals |
Life Science
0%
3/'19 3/'20 3/'21 3/'22 3/'23 3/'24
Copyright©2024 Fuso Chemical Co.,Ltd. All Rights Reserved. | 7 |
Net Profit Analysis FY03/2023 versus FY03/2024
（unit：100 millions of yen）
3/'23 | CGS | selling, | ||
net sales | general and | non‐operating | extraordinary | |
net profit | depreciation | administrative | profit or loss | profit or loss |
exc. depreciation | expenses |
income | 3/'24 |
taxes | net profit |
Copyright©2024 Fuso Chemical Co.,Ltd. All Rights Reserved. | 8 |
Overseas Sales Growth
Net sales | Japan | 50.3% | |
Misc. | |||
700 (unit:100 millions yen) | |||
North America
Asia | 47.0% | 47.0% |
ratio of overseas sales |
600 | 41.8% | 43.6% | ||||
40.5% | ||||||
500 | 340.5 | |||||
400 | 295.5 | 312.7 | ||||
16.4 | ||||||
300 | 250.5 | 240.3 | 238.2 | 11.2 | 114.3 | 6.6 |
200 | 101.1 | 99.9 | ||||
1.2 | 2.1 | 3.6 | ||||
69 | ||||||
75.6 | 74.4 | 213.2 | ||||
100 | 170.3 | |||||
149.6 | ||||||
96.1 | 111.1 | |||||
93.2 | ||||||
0 | ||||||
3/'19 | 3/'20 | 3/'21 | 3/'22 | 3/'23 | 3/'24 | |
(ratio)
50%
40%
30%
20%
10%
0%
Misc. 1.0%
North America
17.0%
FY03/2024
Asia
29.0%
Misc. 0.3%
North America
18.0%
FY03/2019
Asia22.2%
Japan
53.0%
Japan
59.5%
Copyright©2024 Fuso Chemical Co.,Ltd. All Rights Reserved. | 9 |
Assets, Liabilities and Net Assets
Assets | （unit：100millions of yen） | |
1,600 | Current assets | |
1,400 | Non-current | ||
1,200 | assets | ＋127.8 | |
1,000 | 681.3 | ||
800 | 553.4 | ||
600 | ＋74.2 | ||
400 | 656.0 | ||
581.8 | |||
200 | |||
0 | 3/'23 | 3/'24 | |
Liabilities/Net Asset | （unit：100millions of yen） |
1,600
Current liabilities
1,400 Non-current liabilities
1,200 | Net assets | △74.5 | 164.5 |
1,000 | 239.0 | ＋201.4 | 222.5 |
800 | 21.1 | ＋75.2 | |
600 | |||
400 | 875.0 | 950.2 | |
200 | |||
0 | 3/'23 | 3/'24 | |
Copyright©2024 Fuso Chemical Co.,Ltd. All Rights Reserved. | 10 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Fuso Chemical Co. Ltd. published this content on 17 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 May 2024 09:55:02 UTC.
